Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirley Wong

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Phase II study on the addition of ASA404 (vadimezan; 5,6-dimethylxanthenone-4-acetic acid) to docetaxel in CRMPCRoberto Pili, Mark A Rosenthal, Paul N Mainwaring, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2006
Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancerYoland Antill, John Reynolds, Mary-Anne Young, et al.
Kidney International|November 28, 2021
Enteral ferric citrate absorption is dependent on the iron transport protein ferroportinMark R Hanudel, Brian Czaya, Shirley Wong, et al.
Internal Medicine Journal|March 12, 2021
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancerArun A Azad, Ben Tran, Ian D Davis, et al.
Developmental Medicine and Child Neurology|August 17, 2021
Is the search for cerebral palsy 'cures' a reasonable and appropriate goal in the 2020s?Ingrid Honan, Megan Finch-Edmondson, Christine Imms, et al.
Internal Medicine Journal|February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre studyEdmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Novel inhibitors of fatty acid oxidation as potential metabolic modulatorsElfatih Elzein, Kevin Shenk, Prabha Ibrahim, et al.
JCO Global Oncology|March 6, 2026
Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian CohortsWilliam Harris, Sarah Shirley, Elizabeth Liow, et al.
BJU International|July 25, 2015
Patterns of care for metastatic renal cell carcinoma in AustraliaDaphne Day, Yada Kanjanapan, Edmond Kwan, et al.
The Journal of Surgical Research|November 25, 2023
Early Versus Late Feeding After Percutaneous Endoscopic Gastrostomy Placement in Trauma and BurnWhitney Elks, Allison G McNickle, Matthew Kelecy, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Phase II study on the addition of ASA404 (vadimezan; 5,6-dimethylxanthenone-4-acetic acid) to docetaxel in CRMPCRoberto Pili, Mark A Rosenthal, Paul N Mainwaring, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2006
Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancerYoland Antill, John Reynolds, Mary-Anne Young, et al.
Kidney International|November 28, 2021
Enteral ferric citrate absorption is dependent on the iron transport protein ferroportinMark R Hanudel, Brian Czaya, Shirley Wong, et al.
Internal Medicine Journal|March 12, 2021
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancerArun A Azad, Ben Tran, Ian D Davis, et al.
Developmental Medicine and Child Neurology|August 17, 2021
Is the search for cerebral palsy 'cures' a reasonable and appropriate goal in the 2020s?Ingrid Honan, Megan Finch-Edmondson, Christine Imms, et al.
Internal Medicine Journal|February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre studyEdmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Novel inhibitors of fatty acid oxidation as potential metabolic modulatorsElfatih Elzein, Kevin Shenk, Prabha Ibrahim, et al.
JCO Global Oncology|March 6, 2026
Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian CohortsWilliam Harris, Sarah Shirley, Elizabeth Liow, et al.
BJU International|July 25, 2015
Patterns of care for metastatic renal cell carcinoma in AustraliaDaphne Day, Yada Kanjanapan, Edmond Kwan, et al.
The Journal of Surgical Research|November 25, 2023
Early Versus Late Feeding After Percutaneous Endoscopic Gastrostomy Placement in Trauma and BurnWhitney Elks, Allison G McNickle, Matthew Kelecy, et al.
Pageof 8